Mediation of the Total Effect of Cystic Fibrosis-related Diabetes on Mortality: A UK Cystic Fibrosis Registry Cohort Study
Overview
Authors
Affiliations
Aim: To investigate whether the effect of cystic fibrosis-related diabetes (CFRD) on the composite outcome of mortality or transplant could act through lung function, pulmonary exacerbations and/or nutritional status.
Methods: A retrospective cohort of adult cystic fibrosis (CF) patients who had not been diagnosed with CFRD were identified from the UK Cystic Fibrosis Registry (n = 2750). Rate of death or transplant was compared between patients who did and did not develop CFRD (with insulin use) during follow-up using Poisson regression, separately by sex. Causal mediation methods were used to investigate whether lung function, pulmonary exacerbations and nutritional status lie on the causal pathway between insulin-treated CFRD and mortality/transplant.
Results: At all ages, the mortality/transplant rate was higher in both men and women diagnosed with CFRD. Pulmonary exacerbations were the strongest mediator of the effect of CFRD on mortality/transplant, with an estimated 15% [95% CI: 7%, 28%] of the effect at 2 years post-CFRD diagnosis attributed to exacerbations, growing to 24% [95% CI: 9%, 46%] at 4 years post-diagnosis. Neither lung function nor nutritional status were found to be significant mediators of this effect. Estimates were similar but with wider confidence intervals in a cohort that additionally included people with CFRD but not using insulin.
Conclusion: There is evidence that pulmonary exacerbations mediate the effect of CFRD on mortality but, as they are estimated to mediate less than one-quarter of the total effect, the mechanism through which CFRD influences survival may involve other factors.
What the future holds: cystic fibrosis and aging.
Blankenship S, Landis A, Harrison Williams E, Lever J, Garcia B, Solomon G Front Med (Lausanne). 2024; 10:1340388.
PMID: 38264036 PMC: 10804849. DOI: 10.3389/fmed.2023.1340388.
Sebastian-Valles F, Arranz Martin J, Giron R, Knott-Torcal C, Sampedro-Nunez M, Martin-Adan J Biomedicines. 2023; 11(6).
PMID: 37371849 PMC: 10296576. DOI: 10.3390/biomedicines11061754.
Tanner K, Daniel R, Bilton D, Simmonds N, Sharples L, Keogh R Diabet Med. 2022; 39(11):e14958.
PMID: 36075586 PMC: 9826418. DOI: 10.1111/dme.14958.